Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 105, Issue 2, 2010, Pages 155-161

  Esteitie, Rania ^a   DeTineo, Marcy ^a   Naclerio, Robert M ^a   Baroody, Fuad M ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; FLUTICASONE PROPIONATE; MONTELUKAST; PLACEBO; ACETIC ACID DERIVATIVE; ANDROSTANE DERIVATIVE; ANTIINFLAMMATORY AGENT; FLUTICASONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; QUINOLINE DERIVATIVE;

ADD ON THERAPY; ADULT; ARTICLE; ASTHMA; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; OUTCOME ASSESSMENT; PERENNIAL RHINITIS; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SCORING SYSTEM; SKIN TEST; SNEEZING; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADOLESCENT; FEASIBILITY STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; RHINITIS, ALLERGIC, PERENNIAL;

ACETATES; ADOLESCENT; ADULT; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; CHEMOTHERAPY, ADJUVANT; FEASIBILITY STUDIES; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; QUINOLINES; RHINITIS, ALLERGIC, PERENNIAL; SKIN TESTS; TREATMENT OUTCOME;

EID: 77955229219     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.05.017     Document Type: Article

References (29)

1. B. Lundback Epidemiology of rhinitis and asthma Clin Exp Allergy 28 suppl 2 1998 3 10
2. M.S. Dykewicz, and S. Fineman Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis Ann Allergy Asthma Immunol 81 1998 463 468
3. P. van Cauwenberge, C. Bachert, and G. Passalacqua Consensus statement on the treatment of allergic rhinitis: European Academy of Allergology and Clinical Immunology Allergy 55 2000 116 134
4. J. Bousquet, N. Khaltaev, and A.A. Cruz Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy 63 suppl 86 2008 8 160
5. P. Lavie, R. Gertner, and J. Zomer Breathing disorders in sleep associated with "microarousals" in patients with allergic rhinitis Acta Otolaryngol 92 1981 529 533
6. T.J. Craig, S. Teets, and E.B. Lehman Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids J Allergy Clin Immunol 101 1998 633 637
7. B. Leynaert, C. Neukirch, and R. Liard Quality of life in allergic rhinitis and asthma: a population-based study of young adults Am J Respir Crit Care Med 162 2000 1391 1396
8. H.B. Kaiser, R.M. Naclerio, and J. Given Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis J Allergy Clin Immunol 119 2007 1430 1437
9. P.H. Ratner, F. Hampel, and J. Van Bavel Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis Ann Allergy Asthma Immunol 100 2008 74 81
10. P.H. Ratner, J.H. van Bavel, and B.G. Martin A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis J Fam Pract 47 1998 118 125
11. G. Di Lorenzo, M.L. Pacor, and M.E. Pellitteri Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis Clin Exp Allergy 34 2004 259 267
12. M. Kurowski, P. Kuna, and P. Gorski Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation Allergy 59 2004 280 288
13. G. Ciprandi, M.A. Tosca, and M. Milaese Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism Eur Ann Allergy Clin Immunol 36 2004 67 70 72
14. C.E. Baena-Cagnani, W.E. Berger, and L.M. DuBuske Comparative effects of desloratadine versus montelukast on asthma symptoms and use of β2-agonists in patients with seasonal allergic rhinitis and asthma Int Arch Allergy Immunol 130 2003 307 313
15. J. van Adelsberg, G. Philip, and C.F. LaForce Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis Ann Allergy Asthma Immunol 90 2003 214 222
16. G. Philip, K. Malmstrom, and F.C. Hampel Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring Clin Exp Allergy 32 2002 1020 1028
17. A.S. Nayak, G. Philip, and S. Lu Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall Ann Allergy Asthma Immunol 88 2002 592 600
18. P.H. Ratner, W.C. Howland III, and R. Arastu Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast Ann Allergy Asthma Immunol 90 2003 536 542
19. A.M. Wilson, P.M. O'Byrne, and K. Parameswaran Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis Am J Med 116 2004 338 344
20. A.M. Wilson, O.J. Dempsey, and E.J. Sims A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma Clin Exp Allergy 31 2001 616 624
21. E. Pinar, O. Eryigit, and S. Oncel Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis Auris Nasus Larynx 35 2008 61 66
22. E.F. Juniper, and G.H. Guyatt Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis Clin Exp Allergy 21 1991 77 83
23. E.F. Juniper, G.H. Guyatt, and B. Archer Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of "as needed" use J Allergy Clin Immunol 92 1993 66 72
24. A. Jen, F.M. Baroody, and M. Detineo As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis J Allergy Clin Immunol 105 2000 732 738
25. C.M. Baldwin, and L.J. Scott Mometasone furoate: a review of its intranasal use in allergic rhinitis Drugs 68 2008 1723 1739
26. M. Vasar, P.A. Houle, and J.A. Douglass Fluticasone furoate nasal spray: effective monotherapy for symptoms of perennial allergic rhinitis in adults/adolescents Allergy Asthma Proc 29 2008 313 321
27. J.M. Weiner, M.J. Abramson, and R.M. Puy Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials BMJ 317 1998 1624 1629
28. S.M. Mucha, M. deTineo, and R.M. Naclerio Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis Arch Otolaryngol Head Neck Surg 132 2006 164 172
29. A.M. Wilson, P.S. White, and Q. Gardiner Effects of leukotriene receptor antagonist therapy in patients with chronic rhinosinusitis in a real life rhinology clinic setting Rhinology 39 2001 142 146